BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24996662)

  • 1. Evaluation of autofluorescence and toluidine blue in the differentiation of oral dysplastic and neoplastic lesions from non dysplastic and neoplastic lesions: a cross-sectional study.
    Petruzzi M; Lucchese A; Nardi GM; Lauritano D; Favia G; Serpico R; Grassi FR
    J Biomed Opt; 2014; 19(7):76003. PubMed ID: 24996662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
    Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
    Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive visual tools for diagnosis of oral cancer and dysplasia: A systematic review.
    Giovannacci I; Vescovi P; Manfredi M; Meleti M
    Med Oral Patol Oral Cir Bucal; 2016 May; 21(3):e305-15. PubMed ID: 26946204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
    Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
    Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
    Epstein JB; Sciubba J; Silverman S; Sroussi HY
    Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the efficacy of chemiluminescence with lugol's iodine versus toluidine blue in the diagnosis of dysplasia in tobacco associated oral lesions - A diagnostic study.
    Swathi KV; Maragathavalli G; Uma Maheswari TN
    Indian J Dent Res; 2021; 32(4):459-466. PubMed ID: 35645072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
    Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
    Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
    Onofre MA; Sposto MR; Navarro CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
    Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
    Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
    J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toluidine blue versus frozen section for assessment of mucosal tumor margins in oral squamous cell carcinoma.
    Algadi HH; Abou-Bakr AA; Jamali OM; Fathy LM
    BMC Cancer; 2020 Nov; 20(1):1147. PubMed ID: 33238944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions.
    Güneri P; Epstein JB; Kaya A; Veral A; Kazandı A; Boyacioglu H
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):155-61. PubMed ID: 21112183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative analysis of toluidine blue with frozen section in oral squamous cell carcinoma.
    Junaid M; Choudhary MM; Sobani ZA; Murtaza G; Qadeer S; Ali NS; Khan MJ; Suhail A
    World J Surg Oncol; 2012 Apr; 10():57. PubMed ID: 22500814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions-clinical evaluation and review of the literature.
    Kämmerer PW; Rahimi-Nedjat RK; Ziebart T; Bemsch A; Walter C; Al-Nawas B; Koch FP
    Clin Oral Investig; 2015 Mar; 19(2):459-66. PubMed ID: 24888605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Evaluation of the Optical Filter for Autofluorescence Glasses for Oral Cancer Curing Light Exposed (GOCCLES
    Lajolo C; Tranfa M; Patini R; Fiorino A; Musarra T; Boniello R; Moro A
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions.
    Cancela-Rodríguez P; Cerero-Lapiedra R; Esparza-Gómez G; Llamas-Martínez S; Warnakulasuriya S
    J Oral Pathol Med; 2011 Apr; 40(4):300-4. PubMed ID: 21426401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of toluidine blue in the diagnosis and screening of oral cancer and pre-cancer: A systematic review and meta-analysis.
    Kim DH; Song EA; Kim SW; Hwang SH
    Clin Otolaryngol; 2021 Jan; 46(1):23-30. PubMed ID: 32741142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope.
    Ganga RS; Gundre D; Bansal S; Shirsat PM; Prasad P; Desai RS
    Oral Oncol; 2017 Dec; 75():67-74. PubMed ID: 29224826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
    Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
    J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer.
    Epstein JB; Feldman R; Dolor RJ; Porter SR
    Head Neck; 2003 Nov; 25(11):911-21. PubMed ID: 14603451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.